drugset / Trial / NCT05543629
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate BMS-986442 in combination with nivolumab (with or without chemotherapy) for its antitumor efficacy and benefit to participants.
Timeline
- Start
- 2022-10-04
- Primary completion
- 2024-09-12
- Completion
- 2024-09-12
Outcome
Outcome not reported
Stopped (Business): “Business objectives have changed”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986442 | Unknown | — | — |
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Docetaxel | Small molecule | — | — |
| Subject | Nivolumab | Monoclonal antibody | — | — |
| Subject | Paclitaxel | Small molecule | — | — |
| Subject | Pemexetred | Unknown | — | — |